About
Daniel Gomari holds a PhD in Computational Biology and completed a postdoctoral fellowship at Stanford, where he conducted research on machine learning applications in drug repurposing for cancer and metabolic disease, and multi-omics studies on aging. He founded Quinn to address pharmaceutical R&D processes.
Dan Gomari @daniel_gomari
Can confirm LLMs have hit PhD level. Just watched one save a file as processed_final_v2_old_but_better_v3_v2_fixed-ACTUAL.csv while cleaning data. It’s so over.
Feb 17, 2025 · ♥ 5
Dan Gomari @daniel_gomari
Also, boost your wellness with @iollohealth tests alongside your GPT-4 companion. Track 500+ biomarkers, optimize your plan & find connections between actions & biomarker levels. https://t.co/cPQY57wb6l
Mar 24, 2023 · ♥ 1
Dan Gomari @daniel_gomari
Introducing @iollohealth's GPT-4 companion - your personalized wellness partner. Answer a few questions, let it analyze & create a tailored plan, and track your progress via chat interface. Try it out here: https://t.co/JLZt9NxJs4 https://t.co/WNGUmtOh5v
Mar 24, 2023 · ♥ 22 · ⇄ 9
Founder/CEO at QuinnYC S22
Intro paths
Daniel went through Y Combinator (Summer 2022) — any YC alum in your network can reach them through the YC community.
In turn, Daniel can intro founders to Quinn's investors below.